- Perciz defense and homeland security business gaining traction; engaged in active discussions with multiple strategic defense primes in
Israel and abroad; Innoviz LiDARs recognized by MAFAT,Israel's Directorate ofDefense Research and Development - Automotive programs with
VW , Daimler Truck, and others progressing; development projects with other customers on track - Optimizing operations, with a realignment to be implemented in the fourth quarter; expected cost savings of approximately
$17.5 million on an annualized basis vs. the current run rate - Revenues of
$12.1 million in Q3
"Over the past year, we took decisive steps to diversify our business and strengthen our path to long-term growth and profitability," said Omer Keilaf, CEO and Founder of
Commercial and Strategic Updates
- Repositioned Around Two Synergistic End-Markets –
Innoviz now serves two end-markets: automotive, and defense and homeland security under the Perciz brand. The Company expects defense and security to support revenue expansion and gross margin uplift, aided by shorter sales cycle times and ASPs an order of magnitude higher than in automotive, while automotive drives volume growth as programs begin ramping. Defense Orders Shipping –Innoviz has begun delivering initial customer orders and has shipped samples to dozens of additional entities for testing, development, and integration.- Recognized by MAFAT – In September, MAFAT,
Israel's Directorate ofDefense Research and Development, recognized the maturity, robustness, and performance ofInnoviz's LiDAR solutions and their suitability for defense applications. Given MAFAT's worldwide reputation and the extent to which defense capabilities are exchanged betweenIsrael and other nations,Innoviz believes this recognition could help support potential demand among Western defense customers over time. - Strong Engagement at AUSA – At the
Association of the United States Army (AUSA) Annual Meeting and Exposition in October,Innoviz met with dozens of potential customers, including CTOs and senior leaders of leading defense companies and system integrators. - Automotive Programs Progressing – Projects with
VW and Daimler Truck are progressing, along with other Level 3 and Level 4 development programs, including work with LOXO on its Level 4 autonomous delivery platform. - Optimizing Operations – Innoviz is implementing a realignment of its operations to accelerate its progress toward profitability. To maximize efficiencies, the Company will streamline its R&D and operations. As a result of these actions, the Company's workforce will be reduced by approximately 20%, and the Company expects the realignment to deliver cost savings of approximately
$17.5 million on an annualized basis compared to its current run rate.
Q3 2026 Financial Results
Revenues in Q3 2026 were
Operating expenses in Q3 2026 were
Liquidity as of
FY 2026 Financial and Operational Targets[1]
The Company is updating its FY 2026 targets to:
- Revenues of $44–$46 million;
- 2–3 new program wins;
- Perciz revenue ~6-7% of total revenue; and
- New NRE payment plans of $20–$30 million.
Conference Call
Investors are invited to attend by registering in advance here. All relevant information will be sent upon registration.
A replay of the web conference will also be available shortly after the call in the Investors section of
About
Operating across the
Join the discussion: Facebook, LinkedIn, YouTube, X
Media Contact
Media@innoviz-tech.com
Investor Contact
Investors@innoviz-tech.com
[1] As the Company increasingly focuses on the defense market (where new program wins and NRE payment plans are less meaningful measures of performance), the Company does not currently intend to provide guidance on these metrics in future periods.
Forward-Looking Statements
This announcement contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the services and products offered by
"NRE (Non-Recurring Engineering)" is booked services that may be ordered from
Many factors could cause actual future events, and, in the case of our forward-looking revenues and NRE bookings, actual orders or actual payments, to differ materially from the forward-looking statements in this announcement, including but not limited to, the ability to implement business plans, forecasts, and other expectations, the ability to convert design wins into definitive orders and the magnitude of such orders, the ability to achieve broader market adoption of
| | ||||||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||
| | ||||||||
| (Unaudited) | ||||||||
| | ||||||||
| | | Nine Months Ended | | Three Months Ended | ||||
| | | 2026 | | 2025 | | 2026 | | 2025 |
| | | | | | | | | |
| Revenues | $ | 37,315 | $ | 42,415 | $ | 12,098 | $ | 15,278 |
| Cost of revenues | | (39,442) | | (31,575) | | (13,339) | | (12,980) |
| | | | | | | | | |
| Gross profit (loss) | | (2,127) | | 10,840 | | (1,241) | | 2,298 |
| | | | | | | | | |
| Operating expenses: | | | | | | | | |
| Research and development | | 40,747 | | 40,354 | | 12,289 | | 12,372 |
| Sales and marketing | | 6,258 | | 4,183 | | 2,162 | | 1,292 |
| General and administrative | | 16,678 | | 13,109 | | 5,225 | | 4,433 |
| | | | | | | | | |
| Total operating expenses | | 63,683 | | 57,646 | | 19,676 | | 18,097 |
| | | | | | | | | |
| Operating loss | | (65,810) | | (46,806) | | (20,917) | | (15,799) |
| | | | | | | | | |
| Financial income, net | | 1,597 | | 385 | | 1,358 | | 414 |
| | | | | | | | | |
| Loss before taxes on income | | (64,213) | | (46,421) | | (19,559) | | (15,385) |
| Taxes on income | | (108) | | (119) | | (36) | | (34) |
| | | | | | | | | |
| Net loss | $ | (64,321) | $ | (46,540) | $ | (19,595) | $ | (15,419) |
| | | | | | | | | |
| Basic and diluted net loss per ordinary share | $ | (0.27) | $ | (0.24) | $ | (0.07) | $ | (0.08) |
| | | | | | | | | |
| Weighted average number of ordinary shares used | |
238,690,154 | | 196,237,671 | | 276,044,851 | | 203,428,415 |
| | | | | | | | | |
| | |||||
| CONSOLIDATED BALANCE SHEETS | |||||
| | |||||
| (Unaudited) | |||||
| | |||||
| | | | | | |
| | | 2026 | | 2025 | |
| ASSETS | | | | | |
| CURRENT ASSETS: | | | | | |
| Cash and cash equivalents | $ | 22,812 | $ | 8,638 | |
| Short-term restricted cash | | 16 | | 16 | |
| Bank deposits | | 22,736 | | 54,010 | |
| Marketable securities | | 8,855 | | 9,466 | |
| Trade receivables, net | | 10,484 | | 9,978 | |
| Inventory | | 5,227 | | 3,344 | |
| Prepaid expenses and other current assets | | 6,608 | | 4,780 | |
| Total current assets | | 76,738 | | 90,232 | |
| | | | | | |
| LONG-TERM ASSETS: | | | | | |
| Restricted deposits | | 3,321 | | 3,189 | |
| Property and equipment, net | | 19,210 | | 19,856 | |
| Operating lease right-of-use assets, net | | 22,990 | | 25,086 | |
| Other long-term assets | | 850 | | 89 | |
| Total long-term assets | | 46,371 | | 48,220 | |
| Total assets | $ | 123,109 | $ | 138,452 | |
| | | | | | |
| | | | | | |
| LIABILITIES AND SHAREHOLDERS' EQUITY | | | | | |
| CURRENT LIABILITIES: | | | | | |
| Trade payables | $ | 9,594 | $ | 8,599 | |
| Deferred revenues | | 2,523 | | 1,852 | |
| Employees and payroll accruals | | 10,244 | | 9,027 | |
| Accrued expenses and other current liabilities | | 6,984 | | 5,998 | |
| Operating lease liabilities | | 6,236 | | 5,949 | |
| Total current liabilities | | 35,581 | | 31,425 | |
| | | | | | |
| LONG-TERM LIABILITIES: | | | | | |
| Operating lease liabilities | | 27,311 | | 29,302 | |
| Warrants liability | | - | | 7 | |
| Total long-term liabilities | | 27,311 | | 29,309 | |
| | | | | | |
| SHAREHOLDERS' EQUITY: | | | | | |
| Ordinary Shares of no-par value | | - | | - | |
| Additional paid-in capital | | 922,378 | | 875,558 | |
| Accumulated deficit | | (862,161) | | (797,840) | |
| Total shareholders' equity | | 60,217 | | 77,718 | |
| Total liabilities and shareholders' equity | $ | 123,109 | $ | 138,452 | |
| | | | | | |
| | ||||||||
| CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| | ||||||||
| (Unaudited) | ||||||||
| | | Nine Months Ended | | Three Months Ended | ||||
| | | 2026 | | 2025 | | 2026 | | 2025 |
| Cash flows from operating activities: | | | | | | | | |
| Net loss | $ | (64,321) | $ | (46,540) | $ | (19,595) | $ | (15,419) |
| Adjustments required to reconcile net loss to net cash used in operating activities: | | | | | | | | |
| Depreciation and amortization | | 3,914 | | 4,076 | | 1,334 | | 1,361 |
| Remeasurement of warrants liability | | (7) | | (43) | | - | | (13) |
| Change in accrued interest on bank deposits | | 917 | | (931) | | 90 | | (277) |
| Change in marketable securities | | (30) | | (130) | | (14) | | (39) |
| Share-based compensation | | 11,022 | | 11,850 | | 3,344 | | 3,943 |
| Capital gain, net | | (8) | | - | | - | | - |
| Foreign exchange loss (gain), net | | 150 | | (1,326) | | 348 | | (43) |
| Change in prepaid expenses and other assets | | (2,422) | | 1,181 | | (1,877) | | 1,312 |
| Change in trade receivables, net | | (506) | | (13,768) | | 3,298 | | (8,188) |
| Change in inventory | | (1,883) | | 616 | | 134 | | 233 |
| Change in operating lease assets and liabilities, net | | 392 | | 2,813 | | (1,329) | | 422 |
| Change in trade payables | | 1,402 | | 858 | | (4,785) | | 5,422 |
| Change in accrued expenses and other liabilities | | 970 | | (244) | | 927 | | (1,293) |
| Change in employees and payroll accruals | | 1,217 | | 939 | | (1,083) | | 163 |
| Change in deferred revenues | | 671 | | 1,862 | | (499) | | (1,313) |
| Net cash used in operating activities | | (48,522) | | (38,787) | | (19,707) | | (13,729) |
| Cash flows from investing activities: | | | | | | | | |
| Purchase of property and equipment | | (3,885) | | (3,210) | | (1,667) | | (286) |
| Proceeds from sales of property and equipment | | 11 | | 3 | | 7 | | - |
| Investment in bank deposits | | (42,530) | | (77,900) | | (22,600) | | (19,200) |
| Withdrawal of bank deposits | | 72,980 | | 52,350 | | 12,880 | | 18,900 |
| Investment in restricted deposits | | (100) | | (120) | | (100) | | (120) |
| Investment in marketable securities | | (18,551) | | (29,898) | | (8,862) | | (6,967) |
| Proceeds from sales and maturities of marketable securities | | 19,192 | | 32,611 | | 9,649 | | 6,904 |
| Net cash provided by (used in) investing activities | | 27,117 | | (26,164) | | (10,693) | | (769) |
| Cash flows from financing activities: | | | | | | | | |
| Issuance of ordinary shares and warrants, net of issuance costs | | - | | 37,289 | | - | | - |
| Issuance of ordinary shares under the Sales Agreement, net of paid issuance costs | | 7,987 | | 8,419 | | (83) | | 8,419 |
| Issuance of ordinary shares, net of paid issuance costs | | 27,824 | | - | | 27,824 | | - |
| Proceeds from exercise of options | | 43 | | 710 | | - | | 445 |
| Net cash provided by financing activities | | 35,854 | | 46,418 | | 27,741 | | 8,864 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | | (275) | | 1,054 | | (254) | | (15) |
| Increase (decrease) in cash, cash equivalents and restricted cash | | 14,174 | | (17,479) | | (2,913) | | (5,649) |
| Cash, cash equivalents and restricted cash at the beginning of the period | | 8,654 | | 25,381 | | 25,741 | | 13,551 |
| Cash, cash equivalents and restricted cash at the end of the period | $ | 22,828 | $ | 7,902 | $ | 22,828 | $ | 7,902 |
| Share-based compensation expenses: | ||||||||
| | ||||||||
| | | Nine Months Ended | | Three Months Ended | ||||
| | | 2026 | | 2025 | | 2026 | | 2025 |
| | | | | | | | | |
| Cost of revenues | $ | 2,708 | $ | 4,118 | $ | 791 | $ | 1,509 |
| Research and development | | 3,504 | | 4,557 | | 1,045 | | 1,302 |
| Sales and marketing | | 650 | | 552 | | 214 | | 180 |
| General and administrative | | 4,160 | | 2,623 | | 1,294 | | 952 |
| | $ | 11,022 | $ | 11,850 | $ | 3,344 | $ | 3,943 |
| | | | | | | | | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/innoviz-reports-third-quarter-2026-results-302936411.html
SOURCE